Ken Cacciatore
Stock Analyst at TD Cowen
(0.30)
# 4,083
Out of 4,761 analysts
14
Total ratings
25%
Success rate
-30.5%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $13.02 | +284.02% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $7.31 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical Company | Maintains: Outperform | $30 → $20 | $14.06 | +42.25% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $3.25 | +669.23% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $15.75 | +122.22% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $4.68 | +968.15% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $3.72 | +1,244.09% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $36.91 | +21.92% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $23 | $0.59 | +3,804.26% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $375 | $5.77 | +6,399.13% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $13.02
Upside: +284.02%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.31
Upside: -
Takeda Pharmaceutical Company
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $14.06
Upside: +42.25%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $3.25
Upside: +669.23%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $15.75
Upside: +122.22%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $4.68
Upside: +968.15%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $3.72
Upside: +1,244.09%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $36.91
Upside: +21.92%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $23
Current: $0.59
Upside: +3,804.26%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $375
Current: $5.77
Upside: +6,399.13%